Jabalpur (Madhya Pradesh): After 20 children died due to Coldrif cough syrup across Madhya Pradesh, government has escalated its surveillance.
A team from the District Drug Department launched an inspection in Jabalpur. They checked local medical stores to see the quality of cough syrups available in the market.
Officials visited around four medical stores in the Jabalpur and collected samples of various cough syrup brands for laboratory testing.
During the inspection, samples of Respifresh TR and Relief Cough Syrup were found to be inferior which raisied serious health concerns.
The department seized multiple brands of cough syrup and imposed a temporary ban on their sale until further testing confirms their safety standards.
Health officials have also issued an advisory urging parents not to give cough syrup to children below two years of age without a doctor’s prescription, as improper dosage can result in life-threatening risks.
The Drug Department said that the investigations are still ongoing, and strict action will be taken against manufacturers and distributors found guilty of supplying medicines of low quality.
Other suspicious drugs freezed in Chhindwara
The administration has freezed stocks of three Not of Standard Quality (NSQ) cough syrups, including the toxic Coldrif.
Teams of officials visited several medical stores across the district and seized samples of other suspected drugs to prevent a recurrence of any similar tragedy.
“We conducted a whirlwind inspection to freeze bottles of other suspicious drugs along with the three identified NSQ syrups,” said drug inspector Praveen Patel.
